Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.465 USD | +1.56% | +19.04% | +65.60% |
Mar. 19 | North American Morning Briefing : Stock Futures -2- | DJ |
Mar. 14 | Larimar Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+65.60% | 469M | |
-0.94% | 104B | |
+5.83% | 97.47B | |
+5.71% | 22.25B | |
-13.34% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.47% | 16.36B | |
+8.48% | 14.39B | |
+39.73% | 12.37B |
- Stock Market
- Equities
- LRMR Stock
- News Larimar Therapeutics, Inc.
- Citigroup Upgrades Larimar Therapeutics to Buy From Neutral, Price Target is $4.50